CD274 and neoplasm: Another study demonstrated that dominant negative PD-1 receptors without intracellular signaling domains could prevent the inhibitory effect of PD-L1 and PD-L2 on tumor cells and lead to enhanced survival in mesothelioma and lung tumor mouse models [156].